Pamela Lutsey
Oct. 18 event to celebrate participants in long-running and transformative heart health study
The group are part of the nationwide Atherosclerosis Risk in Communities (ARIC) study, which has led to breakthroughs in the management and prevention of heart disease and related conditions.
New Anti-Blood Clot Drugs Appear Safe for Cancer Patients
Associate Professor Pamela Lutsey found that DOAC drugs appear to be just as safe to use as heparin and warfarin for treating venous thromboembolism in cancer patients.
Understanding Patient Drug Preferences for Treating Venous Thromboembolism
Research by Associate Professor Pamela Lutsey found that patients viewed the reversibility of an anticoagulant and the ability to monitor its levels as important.
Study Confirms Link Between Height and Venous Thromboembolism
PhD student Nick Roetker completed a genetics-based study confirming that taller height is related to increased risk of venous thromboembolisms.
